Bertlich, M., Bertlich, I., Plümacher, N., Hadaschik, E., Enk, A., & Hoffmann, J. (2023). High-dose intravenous immunoglobulin co-treatment prolongs time-to-treatment escalation in autoimmune bullous diseases: A monocentric retrospective cohort study. Journal of the European Academy of Dermatology and Venereology, 38(1), . https://doi.org/10.1111/jdv.19437
Chicago-Zitierstil (17. Ausg.)Bertlich, Maya, Ines Bertlich, N. Plümacher, Eva Hadaschik, Alexander Enk, und Jochen Hoffmann. "High-dose Intravenous Immunoglobulin Co-treatment Prolongs Time-to-treatment Escalation in Autoimmune Bullous Diseases: A Monocentric Retrospective Cohort Study." Journal of the European Academy of Dermatology and Venereology 38, no. 1 (2023). https://doi.org/10.1111/jdv.19437.
MLA-Zitierstil (9. Ausg.)Bertlich, Maya, et al. "High-dose Intravenous Immunoglobulin Co-treatment Prolongs Time-to-treatment Escalation in Autoimmune Bullous Diseases: A Monocentric Retrospective Cohort Study." Journal of the European Academy of Dermatology and Venereology, vol. 38, no. 1, 2023, https://doi.org/10.1111/jdv.19437.